A new rapid test for sexually transmitted infections is being developed with £1m funding, aiming to diagnose infections in under 5 minutes. The test, developed by Linear Diagnostics, uses an exponential amplification technology that detects bacterial DNA quickly and accurately.
Researchers at NYU Abu Dhabi have developed a breakthrough paper-based diagnostic device that can detect COVID-19 and other infectious diseases in under 10 minutes. The Radially Compartmentalized Paper Chip (RCP-Chip) is a fast, affordable, and portable solution for on-site screening of infectious diseases.
Diagnostics.AI has launched the industry's first fully-transparent machine learning platform for clinical real-time PCR diagnostics, delivering algorithmic transparency and per-test auditability. The platform is CE-IVDR certified and backed by over 15 years of experience and millions of successfully processed samples.
A new study compares traditional diagnostic decision support systems (DDSSs) to generative AI and finds that DDSSs perform somewhat better. The researchers envision pairing these two approaches to improve diagnostic capabilities and patient outcomes.
A new smartphone app, ECHAS, can help people determine if they are suffering from a heart attack or stroke and need medical attention. The app, developed by experts at UVA Health and other leading institutions, proved effective in identifying patients with cardiac and neurological emergencies.
A new study published in Neurology Open Access found that an MRI scan can accurately diagnose multiple sclerosis (MS) in just 8 minutes, eliminating the need for a painful spinal tap. The study's findings support the use of a T2*-weighted MRI and a 'rule of six' to confirm a diagnosis without lumbar puncture.
Serum Krebs von den Lungen-6 (KL-6) levels are significantly elevated in patients with interstitial lung disease (ILD), suggesting its potential as a diagnostic biomarker. The study also highlights the relationship between KL-6 levels and pulmonary function, specifically forced vital capacity.
A single blood test could identify early-stage cancer in up to half of cases, potentially preventing late-stage disease and improving patient outcomes. Regular MCED testing showed more favourable diagnostic rates than usual care alone, with annual screenings having a higher impact on stage shift.
Two new predictive algorithms use health data and blood tests to identify high-risk patients, offering improved accuracy in diagnosing cancers. The models identified additional medical conditions associated with increased cancer risk and new symptoms indicative of multiple cancer types.
A day-long conference brought together experts to present ground-breaking outcomes research on CTEPH treatments. The session covered new medications, refined techniques, and innovative approaches to improve diagnosis and treatment outcomes.
A new strategy for tuberculosis (TB) screening could significantly improve detection, allowing for simultaneous screening of both active and dormant infections. This approach has the potential to save lives, curb infection rates, and rewrite the story of TB's continued spread.
A recent meta-analysis found that generative AI's diagnostic accuracy is lower than that of specialist doctors, with an average accuracy of 52.1%. The study suggests that while generative AI has the potential to support non-specialist doctors in diagnostics, further research is needed to improve its capabilities.
A new study by the University of Turku found that up to one in six Parkinson's disease diagnoses are later corrected, with most changes occurring within two years. The study highlights the challenges of distinguishing Parkinson's disease from other similar disorders and emphasizes the need for improved diagnostic processes and training.
A recent study reveals critical vulnerabilities in global testing capacity during the COVID-19 pandemic, with socioeconomic disparities playing a significant role. The findings underscore the need for increased diagnostic capacity, equitable access to healthcare, and sustained international cooperation.
Researchers at Tufts University have developed a paper-based device that accurately measures HIV viral loads from dried blood samples, outperforming industry standards. The device, called the plasma spot card, was tested on 75 South African patients and showed improved accuracy in detecting drug-resistant mutations.
A landmark study led by ISGlobal found that combining rapid diagnostic tests with conventional serology improves access to diagnosis for Chagas disease. The prevalence of Chagas is six times higher in an indigenous community in Paraguay compared to the capital.
Researchers introduce persistence barcodes, a tool that reduces diagnostic bias and uncovers subtle details in medical images. The method preserves key structural details, enabling clearer insights into the data.
A study published in Radiology found that radiologists and physicians who received local explanations from artificial intelligence (AI) systems performed better and made faster diagnoses than those who received global explanations. The researchers also found that AI advice was trusted more quickly when it provided local explanations.
A new study published in JAMA Network Open found that using Chat GPT Plus does not significantly improve the accuracy of doctors' diagnoses, but it outperformed conventional methods in certain cases. The researchers suggest that physicians need more training and experience with AI to capitalize on its potential.
A new study from Japan confirms that definitive criteria for lower cachexia prevalence rates are linked to reduced survival rates in cancer patients. The study found that the diagnostic criteria used for cachexia detection can affect reported prevalence and survival outcomes, emphasizing the need for accurate diagnosis.
Radiologists who had access to questionnaire information during MRI interpretation achieved a near statistically perfect agreement with spine specialists. This improved diagnostic accuracy and confidence, avoiding diagnostic discrepancies between radiologists and spine specialists.
A new study finds that AI-powered models exhibit similar levels of accuracy as ophthalmologists in identifying infectious keratitis, a leading cause of corneal blindness worldwide. The AI models displayed a sensitivity and specificity of 89.2% and 93.2%, respectively, matching the diagnostic accuracy of human experts.
Researchers used fluorescein angiography to visualize neural blood flow in rats and rabbits with chronic nerve compression neuropathy, correlating findings with electrodiagnostic testing. The study showed promising results for the method's potential to improve diagnosis and treatment outcomes in carpal tunnel surgery.
A study by Osaka Metropolitan University found that ChatGPT's diagnostic performance for brain tumors was comparable to that of neuroradiologists, with an accuracy rate of 73%. The model's performance varied depending on the type of clinical report written, with higher accuracy when using reports from neuroradiologist writers.
A systematic review of risk stratification tools found high-sensitivity troponin tests to have the highest diagnostic accuracy for ruling out acute coronary syndrome. However, these findings require further validation before recommending their use in primary care settings.
A Kobe University study found that the widely used casual blood glucose testing method for screening pregnant women with gestational diabetes mellitus misses 70% of cases. The researchers recommend using more reliable tests to prevent pregnancy complications and type II diabetes in mothers and children.
A study published in JAMA Network Open found that white patients are more likely to receive related diagnostic testing than Black patients after being discharged from the emergency department. This disparity raises concerns about potential overuse of tests in white patients versus undertesting and missed diagnoses in Black patients.
A recent study by WVU researchers found that smartwatches and clinical testing measures for heart rate variability have significant differences. The study used simulation analysis to determine the validity of wearable devices' calculations, revealing that some methods produce wider ranges of error in measurement.
A new imaging device that combines optical coherence tomography (OCT) with traditional otoscopy improves diagnostic capabilities for hearing clinics. The integrated device provides detailed views of the eardrum and middle ear, enabling more accurate diagnoses and treatment.
Researchers at Osaka Metropolitan University found that AI model GPT-4 outperformed a weaker version of the model and was on par with radiology residents in diagnosing musculoskeletal conditions. However, it struggled to match the accuracy of board-certified radiologists.
Researchers developed an approach to clearly separate physical and psychosocial components of pain, allowing for more targeted treatment. The new method combines measuring body signals, self-disclosure, and computerized evaluation to create two indices: one for physical component and one for psychosocial component.
Researchers found large language models are more accurate with concise, textbook-like medical questions than patient-written summaries. The models achieved higher accuracy when using standardized language, but struggled with variable phrasing and format of patient write-ups.
A new study found that hospital pneumonia diagnoses are often uncertain and revised, with over half of all cases involving a change in diagnosis. This uncertainty can lead to poorer health outcomes for patients who initially lack a pneumonia diagnosis but later receive a diagnosis.
A novel AI tool has been shown to accurately estimate gestational age from blind ultrasound sweeps, comparable to expert sonographers. The technology has the potential to democratize prenatal care in resource-limited settings by expanding access to quality diagnostic tools without the need for expensive equipment or specialized training.
Researchers found high diagnostic accuracy for identifying Alzheimer's disease using amyloid probability score 2 blood test and p-tau217 levels. The study suggests blood tests could influence clinical care, warranting further evaluation.
A study by University of Washington School of Medicine found that a cognitive test is an inaccurate predictor of athletes' concussions. Instead, symptom reports were the most accurate indicator of concussion. The study involved 92 NCAA Division I athletes who sustained a concussion and their teammates as matched control subjects.
Researchers at Queen Mary University of London developed a predictive test using fMRI scans that detects changes in the brain's 'default mode network' to predict dementia. The test showed accurate predictions up to nine years before an official diagnosis, with greater than 80% accuracy and a two-year margin of error.
The study uses the Dermatological Vision Dataset and compares vision transformers with traditional CNNs, achieving an impressive 97.8% accuracy on validation sets. Integrating ViTs into dermatology represents a promising step toward more accurate diagnostics.
The Royal Statistical Society has published new recommendations to improve the evaluation of diagnostic tests, including guidelines on study design, regulation, and transparency. The report aims to prevent future issues with diagnostic test evaluations, particularly those related to infectious diseases.
Researchers identified a unique autoantibody signature in approximately 10% of patients with MS, appearing years before symptom onset. This finding could revolutionize patient care and treatment strategies for multiple sclerosis.
A new lab-on-a-chip system combines optofluidics and nanopores to rapidly test for SARS-CoV-2 and Zika viruses with high accuracy. The tool, developed by UC Santa Cruz researchers, can detect viruses at extremely low concentrations and outperform PCR tests in some cases.
Researchers have developed an AI-driven test that accurately diagnoses ovarian cancer in women clinically classified as normal, improving detection of early-stage disease. The test uses machine learning and blood metabolite information to assign a probability of disease presence or absence, offering a more clinically informative approach.
Diagnostic errors in hospitalized adults who died or were transferred to the intensive care unit were common, with problems in test choice and clinician assessment identified as high-priority areas for improvement. The study analyzed 2,428 patient records at 29 hospitals and found that these errors led to significant patient harm.
A multicenter randomized clinical vignette survey study found that AI models, when systematically biased, reduced diagnostic accuracy. The study involved hospitalist physicians, nurse practitioners, and physician assistants from 13 states.
Researchers developed a fully automated solution using knowledge engineering methods to aggregate independent diagnoses and increased diagnostic accuracy from 46% to 76%. The collective solution improved across various medical specialties, chief complaints, and diagnosticians' tenure levels.
A study by Medical University of Vienna found that AI algorithms in smartphone applications perform well in diagnosing pigmented skin lesions, but are outperformed by doctors in treatment decisions. The 7-class algorithm showed equivalent diagnostic accuracy to experts, while the ISIC algorithm performed worse.
Researchers at the University of Massachusetts Amherst have developed a new method for DNA detection that is 100 times more sensitive than traditional methods. This breakthrough enables fast and accurate disease diagnosis, reducing wait times for lab processing from days to minutes.
A pilot study found that ChatGPT performed as well as doctors in suggesting the most likely diagnoses for patients being assessed in emergency medicine departments. The chatbot generated a list of likely diagnoses and suggested the most likely option, with a large overlap between its shortlist and those of doctors.
A radiomic-based model using T2-weighted MRI data achieved high accuracy in diagnosing pediatric Crohn disease, outperforming expert radiologists. The model was ensembled with clinical data to further improve performance.
A new study found that information-sharing networks among clinicians improve patient care, especially for the worst-performing doctors. The researchers created an app that connected doctors in anonymous networks, showing their peers' diagnostic risk estimates and treatment recommendations.
A new position paper reviews TBS for fracture risk prediction, treatment initiation and monitoring in osteoporosis. The evidence-based guide provides practical guidance for clinicians to integrate TBS into clinical practice.
The American Phytopathological Society has published a focus issue on critical biosecurity gaps in US plant disease diagnostics, highlighting the need for harmonized diagnostics within the agricultural biosecurity system. The focus issue addresses assay validation methods, including high-throughput screening and PCR/RPA techniques.
Columbia University researchers have created a novel, fully organic bioelectronic device that can acquire and transmit neurophysiologic brain signals while providing power to the implanted device. The device features a tiny transistor and has demonstrated high electrical performance, long-term stability, and biocompatibility.
A study published in Radiology found that AI algorithms with high diagnostic accuracy improved radiologists' detection of lung cancers on chest X-rays. High-accuracy AI led to more frequent changes in reader determinations, suggesting increased human trust in AI.
A new device using dielectrophoresis selectively isolates Mycobacterium tuberculosis from sputum samples, providing a purified sample for molecular confirmation. The technology has shown promising results in detecting TB in underserved areas, with high concordance rates compared to culture diagnosis.
Recent studies in the New Journal of Pharmaceutical Analysis feature novel diagnostic tools, RNA sequencing-based workflows, and mechanical property evaluations to enhance cancer and cardiovascular disease treatment outcomes. These innovations aim to improve the therapeutic effect of drugs and promote personalized medicine.
A new method called 5PSeq has been developed to quickly assess bacterial response to antibiotics, with potential implications for treating antibiotic-resistant infections. The method measures mRNA translation and decay, revealing how bacteria interact with environmental factors and stressors.
Researchers developed a 'Skeletal Age' metric to assess impact of fractures on mortality, revealing a loss of one to seven years of life depending on gender, age, and bone site. The online calculator measures bone fragility to help doctors and patients understand fracture risks.
A new laser-based breathalyzer using artificial intelligence can detect COVID-19 in real-time with excellent accuracy. The technology, powered by frequency comb spectroscopy and machine learning, analyzes the unique chemical fingerprint of each breath sample to identify specific health conditions.
A diagnostic study using 4,095 retinal fundus images found that biomarker-based AI algorithms can be susceptible to racial bias, even when trained on raw images. This issue highlights the need for careful evaluation of AI performance in diverse populations.